Advanced glycation products, endoplasmic reticulum stress and the modulation of the reverse cholesterol transport in human arteries with different levels Atherosclerotic lesion

• Grant number: 18/00172-0
• Support Opportunities: Scholarships in Brazil - Post-Doctoral
• Start date: August 01, 2018
• End date: July 31, 2020
• Field of knowledge: Health Sciences - Medicine - Medical Clinics
• Principal Investigator: Marisa Passarelli
• Grantee: Raphael de Souza Pinto
• Host Institution: Faculdade de Medicina (FM). Universidade de São Paulo (USP). São Paulo , SP, Brazil
• Associated research grant: 16/15603-0 - Unraveling mechanisms of glycemic control and chronic complications of Diabetes mellitus: contributions to human health, AP.TEM

Abstract

Advanced Glycation End products (AGE) are independently related to cardiovascular risk. AGE damage lipid homeostasis in the arterial wall by reducing the amount of HDL receptor, ABCA-1, that mediates the excess cholesterol exportation by the reverse cholesterol transport. Mechanistic studies show that this occurs by the induction of oxidative and endoplasmic reticulum stress and inflammation. Nonetheless, there are no studies that analyze, in the same arterial site, the expression of glycoxidative markers and cell injury in association with the reduction in ABCA-1 in different degrees of atherosclerotic lesion. Our hypothesis is that in human arteries, markers of endoplasmic reticulum stress and glycoxidative stress inversely associate with ABCA-1 levels and positively with vascular damage. It will be analyzed in atherosclerotic lesions, obtained by 1) carotid artery endarterectomy and 2) popliteal-femoral segment, the gene expression (RT-qPCR) and proteins levels (immunohistochemistry) of AGE, RAGE, endoplasmic reticulum stress and lipid peroxidation markers and the amount of oxysterols (CG-MS). The mamary artery will be utilized as negative control. In plasma, levels of AGE and soluble RAGE and in the skin, the autofluorescence, will be determined. In plasma, levels of AGE and soluble RAGE will be determined. In the skin, the autofluorescense, will be measured. In vitro assays will be conducted with macrophages cultured in the presence of ER stress inductors and lipid extract from atherosclerotic lesions. This project integrates research from a thematic project approved by FAPESP entitled "Unveiling mechanisms involved in glycemic control and chronic complications of Diabetes Mellitus: contributions to human health", and whose general objective is to discover molecular mechanisms, not yet established, that are related to glycemic control and development of complications of Diabetes Mellitus, seeking to establish proposals that contribute to human health. (AU)

Scientific publications

(6)

(References retrieved automatically from Web of Science and SciELO through information on FAPESP grants and their corresponding numbers as mentioned in the publications by the authors)

MACHADO-LIMA, ADRIANA; LOPEZ-DIEZ, RAQUEL; IBORRA, RODRIGO TALLADA; PINTO, RAPHAEL DE SOUZA; DAFFU, GURDIP; SHEN, XIAOPING; NAKANDAKARE, EDNA REGINA; MACHADO, UBIRATAN FABRES; CORREA-GIANNELLA, MARIA LUCIA CARDILLO; SCHMIDT, ANN MARIE; et al. RAGE Mediates Cholesterol Efflux Impairment in Macrophages Caused by Human Advanced Glycated Albumin. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, v. 21, n. 19, OCT 2020. (12/19112-0, 15/21072-5, 13/06800-9, 18/00172-0, 13/26256-1, 12/12088-7, 14/05951-6, 16/15603-0)

SANTANA, MONIQUE F. M.; LIRA, AECIO L. A.; PINTO, RAPHAEL S.; MINANNI, CARLOS A.; SILVA, AMANDA R. M.; SAWADA, MARIA I. B. A. C.; NAKANDAKARE, EDNA R.; CORREA-GIANNELLA, MARIA L. C.; QUEIROZ, MARCIA S.; RONSEIN, GRAZIELLA E.; et al. Enrichment of apolipoprotein A-IV and apolipoprotein D in the HDL proteome is associated with HDL functions in diabetic kidney disease without dialysis. LIPIDS IN HEALTH AND DISEASE, v. 19, n. 1, p. 14-pg., 2020-09-14. (16/00696-3, 18/00172-0, 17/07725-1, 16/15603-0, 15/21072-5)

PINTO, RAPHAEL S.; FERREIRA, GUILHERME S.; SILVESTRE, GINA CAMILLO R.; SANTANA, MONIQUE DE FATIMA M.; NUNES, VALERIA S.; LEDESMA, LUCAS; PINTO, PAULA R.; DE ASSIS, SAYONARA IVANA S.; MACHADO, UBIRATAN F.; DA SILVA, ERASMO S.; et al. Plasma advanced glycation end products and soluble receptor for advanced glycation end products as indicators of sterol content in human carotid atherosclerotic plaques. Diabetes & Vascular Disease Research, v. 19, n. 1, p. 9-pg., 2022-01-01. (18/00172-0, 16/15603-0, 15/21072-5)

MINANNI, CARLOS ANDRE; MACHADO-LIMA, ADRIANA; IBORRA, RODRIGO TALLADA; OKUDA, LIGIA SHIMABUKURO; PINTO, RAPHAEL DE SOUZA; MELLO SANTANA, MONIQUE DE FATIMA; DE ARAUJO LIRA, AECIO LOPES; NAKANDAKARE, EDNA REGINA; CARDILLO CORREA-GIANNELLA, MARIA LUCIA; PASSARELLI, MARISA. Persistent Effect of Advanced Glycated Albumin Driving Inflammation and Disturbances in Cholesterol Efflux in Macrophages. NUTRIENTS, v. 13, n. 10, OCT 2021. (17/18545-4, 12/19112-0, 16/15603-0, 12/12088-7, 18/00172-0, 15/21072-5)

PINTO, RAPHAEL S.; MINANNI, CARLOS A.; DE ARAUJO LIRA, AECIO LOPES; PASSARELLI, MARISA. Advanced Glycation End Products: A Sweet Flavor That Embitters Cardiovascular Disease. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, v. 23, n. 5, p. 17-pg., 2022-03-01. (18/00172-0, 16/15603-0)

PINTO, R. S.; MACHADO, U. F.; PASSARELLI, M.. Advanced glycation end products as biomarkers for cardiovascular disease: browning clarifying atherogenesis. BIOMARKERS IN MEDICINE, v. 14, n. 8, p. 4-pg., 2020-06-01. (16/15603-0, 18/00172-0)